Preview

FARMAKOEKONOMIKA. Modern Pharmacoeconomic and Pharmacoepidemiology

Advanced search

Search


Order results by:     
 
Issue Title
 
Vol 12, No 1 (2019) Prevalence survey of musculoskeletal and connective tissue disorders in the Russian Federation Abstract  similar documents
T. A. Oleynikova, D. N. Pozhidaeva, A. Yu. Oreshko
"... situation and predict the prevalence of these diseases in Russia for 2018-2019. Materials and methods: we ..."
 
Vol 12, No 3 (2019) Diagnosis-related groups and payments for the treatment of malignant neoplasms in the model of 2019 Abstract  similar documents
D. V. Fedyaev , V. V. Omelyanovskiy , M. L. Lazareva , Yu. V. Seryapina, Yu. A. Ledovskikh
"... of 2019, which resulted from the previous work on the development and revision of the clinical ..."
 
Vol 10, No 1 (2017) THE PREVALENCE OF NON-ALCOHOLIC FATTY LIVER DISEASE IN OUTPATIENTS IN THE FAR EAST FEDERAL DISTRICT Abstract  similar documents
V. A. Nevzorova, M. V. Mokshina, T. A. Brodskaya, D. A. Vasil’chenkov, D. V. Blinov, T. I. Ushakova
"... ). According to the published results of the epidemiological study DIREG 2, the prevalence of NAFLD ..."
 
Vol 12, No 4 (2019) Clinical and economic analysis of drug costs in a general hospital in 2014-2018 Abstract  similar documents
A. T. Burbello, A. S. Fedorenko, E. L. Latariya, M. V. Pokladova, K. A. Zagorodnikova
"... with a simultaneous analysis of case histories. Results. The analysis of drug purchases in 2014-2018 and the obtained ..."
 
Vol 5, No 1 (2012) EСOLOGO-ECONOMIC PROBLEMS OF TECHNOGENIC INFLUENCE OF POLLUTION ON DISEASE OF THE POPULATION Abstract  similar documents
A. I. Borodin, E. M. Ovchinnikov
 
Vol 8, No 3 (2015) NON-ALCOHOLIC FATTY LIVER DISEASE OUTCOMES FUNNEL Abstract  similar documents
D. V. Blinov
"... prevalence of NAFLD within the GP-s patient flow (27%). These findings encourage to conduct a larger sample ..."
 
Vol 9, No 2 (2016) EPIDEMIOLOGICAL FEATURES OF NON-ALCOHOLIC FATTY LIVER DISEASE IN NOVOSIBIRSK (SIBERIAN FEDERAL DISTRICT): REGIONAL DATA OF OPEN MULTICENTER PROSPECTIVE STUDY DIREG 2 Abstract  similar documents
V. V. Tsukanov, A. S. Yurkina, T. A. Ushakova, D. V. Blinov
"... of epidemiological data in Russia has identified the need for a larger study to research the prevalence of NAFLD ..."
 
Vol 9, No 4 (2016) PREVALENCE OF NON-ALCOHOLIC FATTY LIVER DISEASE IN REPUBLIC OF BASHKORTOSTAN (REGIONAL RESULTS OF DIREG 2 STUDY) Abstract  similar documents
D. Kh. Kalimullina, A. S. Yurkina, T. I. Ushakova, D. V. Blinov
"... to evaluate the real prevalence of NAFLD in the Russian population. It is important to know current prevalence ..."
 
Vol 7, No 2 (2014) EPIDEMIOLOGIC RESEARCH ON EPILEPSY IN MINSK Abstract  similar documents
T. V. Dokukina, T. S. Golubeva, I. V. Matveichuk, M. V. Mahrov, V. M. Loseva, E. V. Krupenkina, S. A. Marchuk
"... to improve the situation. Objective: to assess the prevalence profile and management of patients ..."
 
Vol 12, No 3 (2019) Regulatory and legal status of clinical guidelines and their role in the quality control of medical care in countries of the European Union, North America and Asia Abstract  similar documents
V. K. Fedyaeva , U. N. Dmitrieva , N. I. Juravleva , N. I. Juravlev , M. Yu. Kovaleva , A. S. Korobkina , O. A. Sukhorukikh , A. A. Pashkina
"... Introduction. In 2016-2018, the approaches to the development and use of clinical guidelines ..."
 
Vol 5, No 2 (2012) WORKING OUT OF STRATEGY OF STOREKEEPING OF PHARMACEUTICAL FIRM Abstract  similar documents
A. I. Borodin
 
Vol 13, No 2 (2020) Analysis of 19.9 million publications from the PubMed/MEDLINE database using artificial intelligence methods: approaches to the generalizations of accumulated data and the phenomenon of “fake news Abstract  similar documents
I. Yu. Torshin, O. A. Gromova, L. V. Stakhovskaya, N. P. Vanchakova, A. N. Galustyan, Zh. D. Kobalava, T. R. Grishina, A. N. Gromov, I. A. Ilovaiskaya, V. M. Kodentsova, A. G. Kalacheva, O. A. Limanova, V. A. Maksimov, S. I. Malyavskaya, E. V. Mozgovaya, N. I. Tapilskaya, K. V. Rudakov, V. A. Semenov
"... /MEDLINE over the past 50 years (1970–2019) were analyzed. It was shown that publications with low ..."
 
Vol 12, No 4 (2019) Crucial areas of the economic analysis of public cancer care Abstract  similar documents
D. A. Andreev, K. I. Polyakova, A. A. Zavyalov, T. N. Ermolaeva, A. G. Fisun, A. D. Ermolaeva, V. A. Dubovtseva, T. E. Maksimova
"... are expected to be based on 1) prevalence and incidence; 2) impact on health; 3) results of the integrative ..."
 
Vol 8, No 1 (2015) PHARMACOEPIDEMIOLOGICAL EVALUATION OF HEPATOTROPIC THERAPY IN REAL CLINICAL PRACTICE Abstract  similar documents
D. V. Blinov, U. V. Zimovina, T. I. Ushakova
"... show signs of fatty liver (steatosis), alcoholic hepatitis and cirrhosis. Increase in the prevalence ..."
 
Vol 5, No 3 (2012) PHARMACOECONOMIC EVALUATION OF TREATMENT OF SECONDARY HYPERPARATHYROIDISM IN PATIENTS ON DIALYSIS WITH CINACALCET Abstract  similar documents
R. I. Yagudina, V. G. Serpik
"...  hyperparathyroidism to reduce the complications of the cardiovascular system and musculoskeletal system, reduce ..."
 
Vol 13, No 2 (2020) Improvements to the formation of lists of drugs for medical use: analysis of changes in the Government Decree no. 871 Abstract  similar documents
V. V. Omelyanovskiy, E. A. Maksimkina, O. I. Ivakhnenko, M. V. Avxentyeva, M. V. Sura, G. R. Khachatryan
"... No. 871 from August 28, 2014 (with amendments from November 20, 2018). The authors analyzed the historical ..."
 
Vol 8, No 4 (2015) PHARMACOECONOMIC EVALUATION OF INFLUENZA AND PNEUMOCOCCAL VACCINATION IN EMPLOYEES OF THE JOINT STOCK COMPANY "RUSSIAN RAILWAYS" (JSCO "RZD") ON INVESTMENT FOR THE EMPLOYER Abstract  similar documents
D. A. Zhukov
"... , ОРВИ и пневмококковой инфекцией. Оценка достоверности различий в уровне заболеваемости между ..."
 
Vol 12, No 4 (2019) Optimization of drug supply for patients with malignant neoplasms in a region of the Russian Federation Abstract  similar documents
A. V. Nikitina, F. V. Gorkavenko, Y. S. Saybel, M. V. Avxentyeva, M. S. Sura, D. V. Fedyaev
"... of 2018. We calculated the difference between the drug costs in the baseline scenario and the costs ..."
 
Vol 12, No 2 (2019) New framework for the development of clinical guidelines in Russia Abstract  similar documents
D. V. Blinov, E. S. Akarachkova, A. S. Orlova, E. V. Kryukov, D. I. Korabelnikov
"... н of the Ministry of Health of the Russian Federation dated 28 Feb 2019 “Regulations ..."
 
Vol 9, No 2 (2016) MANAGEMENT ASPECT OF THE PROBLEM OF NARCOTIC DRUGS USE Abstract  similar documents
S. Yu. Soboleva, A. V. Sobolev, I. A. Kaminskaya
"... prevalence over medical, bioethics, economic and social aspects. The paper highlights the management ..."
 
Vol 11, No 2 (2018) Regional adaptation of the federal model of reimbursement for medical assistance based on clinical statistical groups: hospitalization of patients in need of genetically enginered biological preparations Abstract  similar documents
M. V. Sura, T. N. Ignatova, N. S. Rudneva, Yu. N. Sukhanova, N. G. Ulyanova, A. S. Khudyaev, V. A. Shelyakin, D. V. Scherbakov
"... ) in 2018 provides for the reimbursement for hospital stay expenses by the compulsory medical insurance fund ..."
 
Vol 8, No 2 (2015) MAGNESIUM DEFICIENCY OF PATIENTS WITH HORMONE DEPENDENT DISEASES: PHARMACOEPIDEMIOLOGICAL PROFILE AND LIFE QUALITY ASSESSMENT Abstract  similar documents
Dmitry Vladislavovich Blinov, Juliana Vladimirovna Zimovina, Elena Anatol'evna Sandakova, Tat'yana Igorevna Ushakova
"... is more studied and known than in gynecology. Prevalence of MD in patients with gynecological diseases ..."
 
Vol 7, No 2 (2014) MANAGEMENT OF MAGNESIUM DEFICIENCY IN PREGNANT WOMEN: PHARMACOEPIDEMIOLOGIC STUDY Abstract  similar documents
D. V. Blinov, U. V. Zimovina, E. M. Dzhobava
"... Background: no multicenter studies to assess the prevalence of Magnesium (Mg) deficiency ..."
 
Vol 11, No 4 (2018) Treatment of patients with malignant lymphoproliferative diseases in the Russian Federation: analysis of the data from 75 regions Abstract  similar documents
G. R. Hachatryan, T. S. Teptsova, V. A. Lemeshko, N. Z. Musina
"... (according to the ICD-10 classification). The questions covered the epidemiology of LPD (prevalence ..."
 
Vol 5, No 3 (2012) PHARMACOECONOMIC EVALUATION OF THE MEDICINAL PRODUCTS ERLOTINIB, DOCETAXEL, PEMETREXED AND GEFITINIB IN THE SECOND-LINE TREATMENT OF LOCALLY-ADVANCED OR METASTATIC NON-SMALL-CELL LUNG CANCER Abstract  similar documents
A. U. Kulikov
"... рак легкого занимает второе место в общей структуре заболеваемости злокачественными ..."
 
Vol 6, No 4 (2013) Pharmacoeconomical assessment of сerebrolysin in the treatment of the acute disturbances of cerebral circulation Abstract  similar documents
A. Yu. Kulikov, L. A. Komarov
"... кровообращения (ОНМК) и составляют порядка 70-80% всех случаев. При этом согласно имеющимся данным заболеваемость ..."
 
Vol 11, No 4 (2018) “Near miss” in obstetrics: classification, evaluation, and significance for healthcare technology assessment Abstract  similar documents
I. K. Мamontova, T. V. Shevlyakovа, E. I. Petrova
"... – «материнская заболеваемость, едва не лишившая женщину жизни» (near miss maternal morbidity), или «near miss ..."
 
Vol 11, No 3 (2018) Ocrelizumab – a monoclonal antibody – in the treatment of adult patients with multiple sclerosis: a systematic review Abstract  similar documents
D. L. Klabukova, M. E. Holownia-Voloskova, M. V. Davydovskaya, T. N. Ermolaeva, K. I. Polyakova, A. G. Fisun, K. A. Kokushkin
"... was conducted in 2018 by using the embase, PubMed, Cochrane and eLibrary.ru databases and the «ocrelizumab ..."
 
Vol 12, No 2 (2019) Concerning the “repression” of ω -3 polyunsaturated fatty acids by adepts of evidence-based medicine Abstract  similar documents
I. Yu. Torshin, O. A. Gromova, Zh. D. Kobalava
"... in 2018 in the Cochrane Database Syst Rev journal under the code number “CD00317F. The authors claim ..."
 
Vol 12, No 2 (2019) Dynamics of prices and consumption of anticancer drugs in Russia after their generics and biosimilars became available Abstract  similar documents
F. V. Gorkavenko, A. V. Nikitina, E. S. Saibel’, M. V. Avksent’eva, M. V. Sura, D. V. Fedyaev
"... in 2010-2018. Results. With an overall downward trend in prices, differences between individual drugs ..."
 
Vol 7, No 3 (2014) MODELI NG CLINICAL AND ECONOMIC OUTCOMES OF TESTING FOR LTBI WITH T-SPOT.TB IN IMMUNOCOMPROMISED CHILDREN Abstract  similar documents
V. I. Ignatyeva, M. V. Avxentyeva, V. V. Omelyanovsky, G. R. Khachatryan
"... on sensitivity and specificity of tests and prevalence of LTBI in Russia. Costs were estimated from the position ..."
 
Vol 6, No 3 (2013) COST-UTILITY ANALYSIS OVER USE OF TYROSINE KINASE INHIBITORS (TASIGNA AND GLEEVEC) FOR TREATMENT OF CHRONIC MYELOID LEUKEMIA IN THE CHRONIC PHASE AS FIRST-LINE THERAPY FOR DE NOVO PATIENTS Abstract  similar documents
R. I. Yagudina, A. Yu. Kulikov, I. A. Komarov
"... заболеваемости для этой патологии – примерно 1-2 случая на 100 000 человек в год. В настоящей статье представлены ..."
 
Vol 12, No 3 (2019) Overview of the existing opportunities and limitations of the state guarantees program for provision of free medical care to citizens Abstract  similar documents
D. V. Fedyaev , R. V. Gostishchev , V. A. Lemeshko , O. I. Ivakhnenko 
"... заболеваемость в регионе.   ..."
 
Vol 12, No 3 (2019) Pharmacoepidemiological analysis of antimicrobial therapy for burn injury in the hospital settings Abstract  similar documents
O. V. Zhukova, E. S. Nekaeva, E. S. Khoroshavina, E. A. Kozlova, Yu. A. Dudukina, I. Yu. Arefyev
"... injuries hospitalized in the Volga University Hospital (Nizhny Novgorod) in 2018. DDD (Defined Daily Dose ..."
 
Vol 12, No 4 (2019) Pharmacoeconomic analysis of using cyclin-dependent kinase 4 and 6 inhibitors in the first line treatment of HR-positive HER2-negative advanced breast cancer Abstract  similar documents
N. A. Avxentyev, E. V. Lubennikova, M. Yu. Frolov
"... за тот же период времени. С учетом сложившихся трендов заболеваемости РМЖ в 2020-2022 гг. в России на ..."
 
1 - 35 of 35 Items

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default articles containing any term in the query are returned (i.e., OR is implied)
  • Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
  • Combine multiple words with AND to find articles containing all terms; e.g., education AND research
  • Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
  • Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)